ID19941A - Sediaan gabungan untuk digunakan pada dementia - Google Patents

Sediaan gabungan untuk digunakan pada dementia

Info

Publication number
ID19941A
ID19941A IDP980209A ID980209A ID19941A ID 19941 A ID19941 A ID 19941A ID P980209 A IDP980209 A ID P980209A ID 980209 A ID980209 A ID 980209A ID 19941 A ID19941 A ID 19941A
Authority
ID
Indonesia
Prior art keywords
dementia
joint provisions
provisions
joint
Prior art date
Application number
IDP980209A
Other languages
English (en)
Indonesian (id)
Inventor
Karl Rudolphi
Hildegard Nimmesgern
Hans-Peter Schubert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID19941A publication Critical patent/ID19941A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
IDP980209A 1997-02-26 1998-02-16 Sediaan gabungan untuk digunakan pada dementia ID19941A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19707655A DE19707655A1 (de) 1997-02-26 1997-02-26 Kombinationspräparat zur Anwendung bei Demenz

Publications (1)

Publication Number Publication Date
ID19941A true ID19941A (id) 1998-08-27

Family

ID=7821517

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP980209A ID19941A (id) 1997-02-26 1998-02-16 Sediaan gabungan untuk digunakan pada dementia

Country Status (30)

Country Link
US (1) US6037347A (zh)
EP (1) EP0867192B1 (zh)
JP (1) JP4374440B2 (zh)
KR (1) KR100517186B1 (zh)
CN (1) CN100363005C (zh)
AR (1) AR011860A1 (zh)
AT (1) ATE295738T1 (zh)
AU (1) AU749278C (zh)
BR (1) BR9800766A (zh)
CA (1) CA2230350C (zh)
CZ (1) CZ298367B6 (zh)
DE (2) DE19707655A1 (zh)
DK (1) DK0867192T3 (zh)
EE (1) EE03387B1 (zh)
ES (1) ES2242243T3 (zh)
HR (1) HRP980097B1 (zh)
HU (1) HUP9800396A3 (zh)
ID (1) ID19941A (zh)
IL (1) IL123453A (zh)
MY (1) MY120530A (zh)
NO (1) NO327200B1 (zh)
NZ (1) NZ329839A (zh)
PL (1) PL191576B1 (zh)
PT (1) PT867192E (zh)
RU (1) RU2194508C2 (zh)
SI (1) SI0867192T1 (zh)
SK (1) SK284925B6 (zh)
TR (1) TR199800302A2 (zh)
TW (1) TW590772B (zh)
ZA (1) ZA981561B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237163T3 (es) * 1998-10-01 2005-07-16 Novartis Ag Nuevas formulaciones orales de revastigmina de liberacion controlada.
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
WO2004028634A1 (en) * 2002-09-25 2004-04-08 The Board Of Trustees Of The University Of Illinois Method and composition for treating alzheimer's disease and dementias of vascular origin
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
MX2007007836A (es) 2004-12-27 2007-08-20 Eisai R&D Man Co Ltd Metodo para estabilizar un farmaco anti-demencia.
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
WO2006118265A1 (ja) * 2005-04-28 2006-11-09 Eisai R & D Management Co., Ltd. 抗痴呆薬を含有する組成物
EP4019018A1 (en) 2015-09-11 2022-06-29 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
US3621096A (en) * 1969-04-03 1971-11-16 Univ North Carolina Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2856393C2 (de) * 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel
JPH05506842A (ja) * 1989-09-15 1993-10-07 ジェンシア・ファーマシュウティカルズ・インコーポレイテッド 神経変性状態の処置方法
DE4236331A1 (de) * 1992-10-28 1994-05-05 Boehringer Ingelheim Kg Synergistische Kombination
US5783584A (en) * 1995-12-11 1998-07-21 Mayo Foundation For Medical Education And Research THA analogs useful as cholinesterase inhibitors
GB9612710D0 (en) * 1996-06-18 1996-08-21 Pfizer Ltd Method of treatment

Also Published As

Publication number Publication date
HRP980097B1 (en) 2006-09-30
ATE295738T1 (de) 2005-06-15
CA2230350A1 (en) 1998-08-26
AU5627398A (en) 1998-09-03
KR19980071717A (ko) 1998-10-26
KR100517186B1 (ko) 2005-12-05
AR011860A1 (es) 2000-09-13
HUP9800396A3 (en) 2001-05-28
NO980786L (no) 1998-08-27
TR199800302A3 (tr) 1998-09-21
PL325074A1 (en) 1998-08-31
NO980786D0 (no) 1998-02-25
EP0867192A3 (de) 2000-12-06
MY120530A (en) 2005-11-30
IL123453A (en) 2004-06-20
CN1192904A (zh) 1998-09-16
EP0867192A2 (de) 1998-09-30
HU9800396D0 (en) 1998-04-28
TR199800302A2 (xx) 1998-09-21
DK0867192T3 (da) 2005-09-05
RU2194508C2 (ru) 2002-12-20
EE9800075A (et) 1998-10-15
CA2230350C (en) 2007-07-24
PL191576B1 (pl) 2006-06-30
SI0867192T1 (en) 2005-10-31
SK24098A3 (en) 1998-09-09
DE19707655A1 (de) 1998-08-27
HUP9800396A1 (hu) 1999-07-28
CN100363005C (zh) 2008-01-23
EP0867192B1 (de) 2005-05-18
HRP980097A2 (en) 1998-12-31
DE59812801D1 (de) 2005-06-23
NO327200B1 (no) 2009-05-11
JP4374440B2 (ja) 2009-12-02
BR9800766A (pt) 1999-12-07
MX9801515A (es) 1998-08-30
AU749278C (en) 2003-07-31
EE03387B1 (et) 2001-04-16
AU749278B2 (en) 2002-06-20
PT867192E (pt) 2005-08-31
SK284925B6 (sk) 2006-02-02
CZ54098A3 (cs) 1998-09-16
TW590772B (en) 2004-06-11
US6037347A (en) 2000-03-14
JPH10236979A (ja) 1998-09-08
ZA981561B (en) 1998-08-26
NZ329839A (en) 2000-05-26
CZ298367B6 (cs) 2007-09-12
ES2242243T3 (es) 2005-11-01
IL123453A0 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
IT1273501B (it) Snodo omocinetico
FR2726869B1 (fr) Joint homocinetique
NO975091D0 (no) Frigjörbar flersyklus-forbindelse
ID20885A (id) Peralatan elektrolit padu untuk digunakan pada tanur-tanur
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DK0916051T3 (da) Linieindretningsredskab
DE69710440D1 (de) Gelenkanordnung
ID19941A (id) Sediaan gabungan untuk digunakan pada dementia
FI962420A0 (fi) Foerstaerkare med laogbrus
ID24883A (id) Apitan-hubung pada kapal
DE9419608U1 (de) Gelenkglied
DE69811218D1 (de) Tongeber
DE69830081D1 (de) Zwischenstück
IT1290089B1 (it) Snodo bipode
DE59704868D1 (de) Gelenk
DE59712815D1 (de) Aussenspiegelgelenk
DE29618314U1 (de) Gelenk
FR2723991B1 (fr) Joint homocinetique
NO994815D0 (no) Skjöte-anordning
NO993024L (no) Polysakkarid-peptid-derivater
FI971548A0 (fi) Komplexa estrar avsedda att anvaendas med fluorerade koeldmedel
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
IT1290143B1 (it) Snodo bipode
KR970063151U (ko) 이음관